Kore Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Kore Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,558	Closed	-$211K	–	473
2021 Q2	$211K	Buy	+1,558	New	+$205K	0.02%	386
2020 Q3	–	Sell	-438	Closed	-$49K	–	1103
2020 Q2	$49K	Sell	438 -36	-8%	-$3.55K	0.01%	461
2020 Q1	$37K	Buy	+474	New	+$42K	0.01%	478
2019 Q2	–	Sell	-552	Closed	-$50K	–	798
2019 Q1	$50K	Buy	+552	New	+$47K	0.01%	383

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kore Private Wealth's XBI Position: Q3 2021 in Review

Kore Private Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 1,558 shares — an estimated $211K sold.

Kore Private Wealth first reported a position in XBI in Q1 2019 and held it in 4 quarters. The position peaked at $211K in Q2 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Kore Private Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
Kore Private Wealth sold 1,558 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $211K.
Kore Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 4 quarters.
Kore Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $211K in Q2 2021.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Kore Private Wealth's 13F filing for Q3 2021, filed 15 Nov 2021.